Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 10530
mi
from
Tacoma, WA
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 10530
mi
from
Tacoma, WA
Click here to add this to my saved trials
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 10170
mi
from
Greenfield, WI
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 10170
mi
from
Greenfield, WI
Click here to add this to my saved trials
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 13001
mi
from
Royal Oak, MI
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 13001
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 10393
mi
from
Greenville, SC
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 10393
mi
from
Greenville, SC
Click here to add this to my saved trials
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 10793
mi
from
Sugar Land, TX
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 10793
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated:  12/8/2015
Teva Investigational Site 11065
mi
from
Toronto,
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
A 12-Week, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone/Salmeterol Multidose Dry Powder Inhaler in Adolescent and Adult Patients With Persistent Asthma Symptomatic Despite Inhaled Corticosteroid Therapy
Status: Enrolling
Updated: 12/8/2015
Teva Investigational Site 11065
mi
from
Toronto,
Click here to add this to my saved trials
Case Management and Environmental Control in Asthma
Status: Enrolling
Updated:  12/8/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Case Management and Environmental Control in Asthma
Status: Enrolling
Updated: 12/8/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)
Evaluation of the Bronchoprotective Effect of Arformoterol in Children With Exercise Induced Bronchospasm
Status: Enrolling
Updated:  12/9/2015
University of New Mexico
mi
from
Albuquerque, NM
Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)
Evaluation of the Bronchoprotective Effect of Arformoterol in Children With Exercise Induced Bronchospasm
Status: Enrolling
Updated: 12/9/2015
University of New Mexico
mi
from
Albuquerque, NM
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
University of Arizona
mi
from
Tucson, AZ
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
National Jewish Health
mi
from
Denver, CO
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Nemours Children's Clinic
mi
from
Jacksonville, FL
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Indiana University
mi
from
Indianapolis, IN
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
University of Missouri, Kansas City School of Medicine
mi
from
Kansas City, MO
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
University of Missouri, Kansas City School of Medicine
mi
from
Kansas City, MO
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
New York Medical College
mi
from
Valhalla, NY
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Duke Univ Med Ctr
mi
from
Durham, NC
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
University of California, San Diego
mi
from
San Diego, CA
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
University of Miami School of Medicine
mi
from
Miami, FL
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
University of South Florida College of Medicine
mi
from
Tampa, FL
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
University of South Florida College of Medicine
mi
from
Tampa, FL
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Louisiana State University Health Sciences Center
mi
from
New Orleans, LA
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Louisiana State University Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Washington University School of Medicine
mi
from
St. Louis, MO
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
North Shore-Long Island Jewish Health System
mi
from
New Hyde Park, NY
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
North Shore-Long Island Jewish Health System
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
New York University School of Medicine
mi
from
New York, NY
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Baylor College of Medicine
mi
from
Houston, TX
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated:  12/10/2015
Vermont Lung Center at The University of Vermont
mi
from
Burlington, VT
The Study of Soy Isoflavones in Asthma
The Study of Soy Isoflavones in Asthma
Status: Enrolling
Updated: 12/10/2015
Vermont Lung Center at The University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial
Status: Enrolling
Updated:  12/15/2015
Jacobi Medical Center
mi
from
Bronx, NY
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial
Status: Enrolling
Updated: 12/15/2015
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial
Status: Enrolling
Updated:  12/15/2015
Nassau University Medical Center
mi
from
East Meadow, NY
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial
Status: Enrolling
Updated: 12/15/2015
Nassau University Medical Center
mi
from
East Meadow, NY
Click here to add this to my saved trials
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial
Status: Enrolling
Updated:  12/15/2015
Long Island Jewish Medical Center
mi
from
Queens, NY
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Emergency Department (ED) Use of Nebulized Budesonide as an Adjunct to Standardized Therapy in Acutely Ill Adults With Refractory Asthma: a Randomized, Double-blinded, Placebo-controlled Trial
Status: Enrolling
Updated: 12/15/2015
Long Island Jewish Medical Center
mi
from
Queens, NY
Click here to add this to my saved trials
Evaluation of VLER-Indiana Health Information Exchange Demonstration Project
Evaluation of VLER_Indiana Health Information Exchange Demonstration Project
Status: Enrolling
Updated:  12/22/2015
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Evaluation of VLER-Indiana Health Information Exchange Demonstration Project
Evaluation of VLER_Indiana Health Information Exchange Demonstration Project
Status: Enrolling
Updated: 12/22/2015
Richard L. Roudebush VA Medical Center, Indianapolis, IN
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
1222.29.11004 Boehringer Ingelheim Investigational Site
mi
from
North Dartmouth, MA
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
1222.29.11004 Boehringer Ingelheim Investigational Site
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Oklahoma City, OK
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Denver, CO
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
1218.64.10009 Boehringer Ingelheim Investigational Site
mi
from
Arlington, TX
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
1218.64.10009 Boehringer Ingelheim Investigational Site
mi
from
Arlington, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
San Antonio, TX
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
Boehringer Ingelheim Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
205.445.01013 Boehringer Ingelheim Investigational Site
mi
from
Rolling Hills Estates, CA
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
205.445.01013 Boehringer Ingelheim Investigational Site
mi
from
Rolling Hills Estates, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
1199.222.1004 Boehringer Ingelheim Investigational Site
mi
from
North Charleston, SC
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
1199.222.1004 Boehringer Ingelheim Investigational Site
mi
from
North Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated:  12/22/2015
1200.75.54005 Boehringer Ingelheim Investigational Site
mi
from
Buenos Aires,
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Children (6 to 11 Years Old) With Severe Persistent Asthma
Status: Enrolling
Updated: 12/22/2015
1200.75.54005 Boehringer Ingelheim Investigational Site
mi
from
Buenos Aires,
Click here to add this to my saved trials
Childhood Asthma Program in NYC Health Department Clinics
Improving Care for Minority Children With Asthma: Professional Education in Public Health Clinics
Status: Enrolling
Updated:  12/22/2015
Columbia University
mi
from
New York, NY
Childhood Asthma Program in NYC Health Department Clinics
Improving Care for Minority Children With Asthma: Professional Education in Public Health Clinics
Status: Enrolling
Updated: 12/22/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate the Use of ASTHMA IQ in a Primary Care Setting
Examination of ASTHMA IQ to Improve Patient Outcomes in a Primary Care Setting
Status: Enrolling
Updated:  1/4/2016
AAFP National Research Network
mi
from
Leawood, KA
To Evaluate the Use of ASTHMA IQ in a Primary Care Setting
Examination of ASTHMA IQ to Improve Patient Outcomes in a Primary Care Setting
Status: Enrolling
Updated: 1/4/2016
AAFP National Research Network
mi
from
Leawood, KA
Click here to add this to my saved trials
A Pilot Stress Management Intervention Study for High Risk Children With Asthma
A Pilot Stress Management Intervention for High Risk Children With Asthma
Status: Enrolling
Updated:  1/4/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
A Pilot Stress Management Intervention Study for High Risk Children With Asthma
A Pilot Stress Management Intervention for High Risk Children With Asthma
Status: Enrolling
Updated: 1/4/2016
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Status: Enrolling
Updated:  1/5/2016
National Institue Of Fitness and Sport
mi
from
Indianapolis, IN
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Status: Enrolling
Updated: 1/5/2016
National Institue Of Fitness and Sport
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma
A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma
Status: Enrolling
Updated:  1/5/2016
Alameda County Medical Center
mi
from
Oakland, CA
Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma
A Randomized Double-Blind Controlled Trial of Single Oral Dose Dexamethasone Versus Five Days of Oral Prednisone in Acute Mild to Moderate Adult Asthma
Status: Enrolling
Updated: 1/5/2016
Alameda County Medical Center
mi
from
Oakland, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated:  1/6/2016
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated: 1/6/2016
Boehringer Ingelheim Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated:  1/6/2016
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated: 1/6/2016
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated:  1/6/2016
1268.17.01012 Boehringer Ingelheim Investigational Site
mi
from
El Paso, TX
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated: 1/6/2016
1268.17.01012 Boehringer Ingelheim Investigational Site
mi
from
El Paso, TX
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated:  1/6/2016
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution (2.5 mcg and 5 mcg) Delivered Via Respimat® Inhaler Once Daily in the Evening Over 48 Weeks in Children (6 to 11 Years Old) With Moderate Persistent Asthma
Status: Enrolling
Updated: 1/6/2016
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials